Printer Friendly

ARROW INTERNATIONAL REPORTS SALES UP 14 PERCENT FOR THE QUARTER AND 12 PERCENT FOR THE FISCAL YEAR

 READING, Pa., Sept. 8 /PRNewswire/ -- Arrow International, Inc. (NASDAQ-NMS: ARRO) announced today that unaudited net sales for the fiscal year ended Aug. 31, 1993, were approximately $150 million, up about 12 percent from $133.4 million in fiscal 1992.
 Net sales for the fourth quarter were approximately $41 million, up about 14 percent from $35.9 million in the comparable quarter of fiscal 1992. Marlin Miller Jr., president and CEO, said these results were in line with company expectations for fiscal 1993 in view of new product approval delays related to the large backlog at the FDA and a softer U.S. hospital market attributed to medical cost containment efforts. The company plans to release earnings results for the quarter and full year during the last week in September and continues to consider analysts' estimates of earnings per share of $1.05-$1.06 for the 1993 fiscal year to be reasonable.
 Although fiscal 1993 revenue growth was below the company's longer term objective of 20 percent, Miller estimated that with new products which were introduced or cleared in 1993 and with expanded international sales initiatives, an increase in revenue in the range of 20 percent is a reasonable target for fiscal 1994, based on current market conditions.
 In late August the FDA cleared the company's new TrueTorque(TM) guidewire for sale in the United States. Evaluation quantities of this product, designed to facilitate the placement of catheters used in cardiovascular procedures, will be shipped during September. Previously announced 1993 fiscal year product introductions included the company's Super ArrowFlex(TM) sheath, QuickFlash(TM) radial artery catheter, quadripolar mapping catheter, and EVAN(TM) arterial access needle.
 The company continues to expand its presence in international markets. In late August manufacturing was started in a newly acquired 40,000 square foot plant in Chihuahua, Mexico. This plant will support marketing initiatives in Latin America and produce certain components for products packaged in the United States. After the close of business on Aug. 31, 1993, the company purchased its distributor in The Netherlands, Diarmed Medical Disposable Products B.V. Miller stated that Arrow International was pleased to have the opportunity to acquire this company to continue the development of Arrow's business in Holland. Arrow now has direct European sales representation in Germany, France and The Netherlands, as well as direct sales subsidiaries serving markets in Japan, Africa and Canada.
 Arrow International, Inc. develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products. The company's products are used primarily in critical care procedures by anesthesiologists, critical care specialists, surgeons, cardiologists and emergency and trauma physicians.
 The company's shares are traded in the over-the-counter market on the NASDAQ National Market System under the symbol ARRO.
 /delval/
 -0- 9/8/93
 /CONTACT: Marlin Miller Jr., 215-478-3114, or John H. Broadbent Jr., 215-478-3116, both of Arrow International/
 (ARRO)


CO: Arrow International, Inc. ST: Pennsylvania IN: MTC SU:

JM-CC -- PH036 -- 0024 09/08/93 17:33 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 8, 1993
Words:494
Previous Article:FEDERAL TRADE COMMISSION REQUESTS ADDITIONAL INFORMATION FROM QVC
Next Article:THOMAS F. RIPKE JR. OF WEST ONE BANK ELECTED SECOND VICE PRESIDENT OF ROBERT MORRIS ASSOCIATES
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters